Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-18-004889
Filing Date
2018-03-08
Accepted
2018-03-08 15:16:53
Documents
90
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K drrx-10k_20171231.htm 10-K 3428334
2 EX-12.1 drrx-ex121_8.htm EX-12.1 87517
3 EX-23.1 drrx-ex231_6.htm EX-23.1 17575
4 EX-31.1 drrx-ex311_10.htm EX-31.1 16964
5 EX-31.2 drrx-ex312_7.htm EX-31.2 17002
6 EX-32.1 drrx-ex321_9.htm EX-32.1 4231
7 EX-32.2 drrx-ex322_11.htm EX-32.2 4305
8 GRAPHIC g2018030819043532048700.jpg GRAPHIC 33602
  Complete submission text file 0001564590-18-004889.txt   12176619

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT drrx-20171231.xml EX-101.INS 2863362
10 XBRL TAXONOMY EXTENSION SCHEMA drrx-20171231.xsd EX-101.SCH 70391
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE drrx-20171231_cal.xml EX-101.CAL 68094
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE drrx-20171231_def.xml EX-101.DEF 267322
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE drrx-20171231_lab.xml EX-101.LAB 547501
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE drrx-20171231_pre.xml EX-101.PRE 469401
Mailing Address 10260 BUBB ROAD CUPERTINO CA 95014
Business Address 10260 BUBB RD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31615 | Film No.: 18676187
SIC: 2834 Pharmaceutical Preparations